Episurf Medical
First Episealer® surgery in Malaysia scheduled
Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery in Malaysia with the knee implant Episealer® has been scheduled.
"We are committed to developing our commercial strategy in the APAC region, we have started slowly, with a few market registrations of which Malaysia has been one, so it is exciting to get started here. Over the coming months we will invest in accelerating our commercial strategy for the APAC region. We appreciate the support we receive from our local partners and this partnership will get stronger as we grow," comments Stephen Caswell, Head of Sales OUS, Episurf Medical.
| Datum | 2023-03-16, kl 08:30 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!